Nanopath is a molecular diagnostics company disrupting traditional testing methodologies. We aim to improve the health of women by providing granular and clinically actionable information within a single office visit.
Location: United States, Massachusetts, Cambridge
Employees: 1-10
Total raised: $14M
Founded date: 2019
Founders name: Flavio Antonio Franchina
Founders Related Locations: Haiti, Centre, Hinche; United States, Massachusetts, Cambridge
Investors 4
| Date | Name | Website |
| - | Undeterred... | undeterred... |
| - | Creative D... | creativede... |
| - | Norwest Ve... | nvp.com |
| 15.08.2022 | GingerBrea... | gingerbrea... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 22.05.2024 | Grant | $4M | - |
| 17.08.2022 | Series A | $10M | - |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Flavio Ant... | Franchina | Co-Founder... | linkedin.c... | - | - |
Mentions in press and media 11
| Date | Title | Description |
| 22.05.2024 | Nanopath's Groundbreaking Approach to Women's Health Diagnostics | In a groundbreaking move, Nanopath Inc., a cutting-edge point-of-care diagnostics company based in Cambridge, Massachusetts, has recently secured a substantial $4 million in federal grants. This funding injection, comprising a $3 million gr... |
| 22.05.2024 | Nanopath Awarded $4M Grant to Support Point-of-Care Molecular Diagnostics for Women’s Health | What You Should Know: – Nanopath Inc., a point-of-care diagnostics company enabling high-quality molecular testing in minutes, announced today that it was awarded $4 million in federal funding. – The company was awarded a $3 million grant f... |
| 21.05.2024 | Nanopath Receives $4M in Grants | Nanopath Inc., a Cambridge, Mass.-based point-of-care diagnostics company enabling high-quality molecular testing in minutes, received $4m in federal funding. The company was awarded: a $3m grant from the National Institutes of Health (NIH)... |
| 21.05.2024 | Nanopath Receives $4 Million in Grants from National Institutes of Health and National Science Foundation | CAMBRIDGE, Mass., May 21, 2024 /PRNewswire/ -- Nanopath Inc., a point-of-care diagnostics company enabling high-quality molecular testing in minutes, announced today that it was awarded $4 million in federal funding. The company was awarded... |
| 17.08.2022 | Nanopath lands $10M for biosensing platform | Dartmouth College spinoff Nanopath Inc. closed a $10 million series A funding round to commercialize a point-of-care biosensing platform with ultrasensitive optical detection. The startup is developing a rapid test that provides genetic inf... |
| 10.08.2022 | Nanopath Raises $10M in Series A Funding | Nanopath, a Cambridge, MA-based molecular diagnostics company, raised $10M in Series A funding. The round was led by Norwest Venture Partners and the Medtech Convergence Fund, with participation from Gingerbread Capital and Green D Ventures... |
| 10.08.2022 | Femtech Startup Nanopath Raises $10M to Develop POC Diagnostics for Women’s Health | What You Should Know: Nanopath Co-Founders Dr. Amogha Tadimety (Left) and Dr. Alison Burklund (Right) Founded by Dr. Amogha Tadimety and Dr. Alison Burklund to address disparities in women’s health and with a platform that is designed to be... |
| 09.08.2022 | Nanopath Secures $10 Million in Series A Funding to Develop and Commercialize Point-of-Care Diagnostics for Women's Health | Norwest and Medtech Convergence Fund co-lead investment in molecular diagnostic company working to improve diagnostic testing for women's health screening |
| 09.08.2022 | Nanopath raises $10M to be a diagnostic platform for women | The company wants to be the go-to system for routine women’s health screening at the point-of-care While the femtech space may be booming, reaching over $1 billion for the first time ever in 2021, that still only accounts for 7% of all doll... |
| 09.08.2022 | Nanopath Raises $10M Series A Funding Round | CAMBRIDGE, MA, Nanopath, a molecular diagnostics company enabling high-quality molecular testing in minutes, announced today that it has closed $10 million in Series A funding. >> Click here for more funding data on Nanopath >&... |
Show more